FDA Import Refusal AEK-7507398-9/10002/1 — Novartis Pharma AG
The FDA refused shipment AEK-7507398-9/10002/1 from Novartis Pharma AG (Switzerland) on September 2, 2025. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 2, 2025
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 118,75